FIELD: medicine.
SUBSTANCE: present invention refers to compositions for treating a symptom associated with menopause, and for treating a symptom associated with osteoporosis. Compositions contain an effective dosage of the ospemifene solid dispersion, wherein said solid dispersion contains ospemifene and a hydrophilic carrier selected from a group consisting of copovidone, polyvinylpyrrolidine, a copolymer of polyvinylpyrrolidine and vinyl acetate, hydroxypropyl methylcellulose, hypromellose succinate acetate, a copolymer of methacrylic acid, hydroxypropyl cellulose, a graft copolymer of polyvinyl caprolactam/polyvinyl acetate/polyethylene glycol, hydroxypropyl methylcellulose phthalate and mixtures thereof. Invention also relates to aqueous solutions for treating a symptom associated with menopause, and for treating a symptom associated with osteoporosis, to a method of producing a composition, to pharmaceutical compositions, to a method of treating a symptom associated with menopause, and a method of treating osteoporosis.
EFFECT: technical result consists in increasing the bioavailability of drugs, poorly soluble in water, and reducing the dose of such drugs.
33 cl, 29 dwg, 10 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITION OF NANOSTRUCTURED APREPITANT, SYNTHESIS METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | 2011 |
|
RU2595841C2 |
APIXABAN LIQUID FORMULATIONS | 2013 |
|
RU2660358C2 |
PHARMACEUTICAL COMPOSITION HAVING ANTI-HIV INFECTION ACTIVITY | 2017 |
|
RU2659693C1 |
SOLID DISPERSIONS AND PHARMACEUTICAL COMPOSITIONS INCLUDING SUBSTITUTED INDANE, AND METHODS FOR PRODUCTION AND APPLICATION THEREOF | 2019 |
|
RU2772693C1 |
COMPOSITIONS OF SOLID DOSAGE FORMS OF OREXIN RECEPTOR ANTAGONIST | 2013 |
|
RU2759837C2 |
SOLID TABLETS AND CAPSULES OF MODIFIED RELEASE OF BENZONATATE | 2014 |
|
RU2673239C2 |
COMPOSITIONS OF SOLID DOSAGE FORMS OF AN OREXIN RECEPTOR ANTAGONIST | 2013 |
|
RU2699358C2 |
PHARMACEUTICAL COMPOSITIONS CONTAINING DIACEREIN | 2009 |
|
RU2542461C2 |
SOLID DISPERSIONS CONTAINING APOPTOSIS PROMOTING PROTEINS | 2010 |
|
RU2550134C2 |
TABLETS OF TAMSULOSIN WITH MODIFIED RELEASE | 2002 |
|
RU2335280C2 |
Authors
Dates
2019-07-17—Published
2016-03-10—Filed